Information Management Systems Enable Manufacturing Facilities to Ramp Up Productivity - Reporting requirements and safety regulations make reliable IT systems a high priority at the manufacturing lev


Information Management Systems Enable Manufacturing Facilities to Ramp Up Productivity
Reporting requirements and safety regulations make reliable IT systems a high priority at the manufacturing level.

BioPharm International

Figure 1. An Electronic Batch Record System An electronic batch record (EBR) system draws data from many systems in pharma manufacturing plants. The network infrastructures between and within the systems are breeding grounds for outages and system interruptions and must be factored into plans for implementing an EBR system.
However, this new paradigm will be a challenge to pharma executives because it is not a simple matter of extending conventional corporate IT systems and management approaches down to the manufacturing plant level. Reporting requirements and public safety regulations make IT systems reliability a much higher priority at the manufacturing level than in the general corporate IT environment. Outages and glitches common in corporate infrastructures are a much more serious issue in pharmaceutical manufacturing. If a pharma company can't document every step it takes to set up, process, and verify a batch, US and European regulations compel them to scrap it. EBR systems, for example, must collect data constantly because even one break in the electronic record chain can turn a million-dollar batch of medication into that quarter's biggest loss. For PAT to provide real-time quality control and key process parameter recording, its underlying computing infrastructure must be free of crashes and service interruptions.

That need — for much higher reliability than conventional IT infrastructures provide — demands a new mindset from pharma executives, many of whom have solid backgrounds in corporate and scientific IT, but not in manufacturing IT. The mainstream business approach of consolidating IT systems at corporate data centers does not apply to manufacturing. Manufacturing data collection systems must be situated in relatively close proximity to the process, not at a remote data center. Plant-level IT staffs, however, don't have the resources or expertise to maintain the ultra-high reliability – 99.999 percent uptime – infrastructure that this new pharma manufacturing IT paradigm demands.

The challenge for pharma executives is to implement at the plant-level technologies and management practices that eliminate crashes, service interruptions, and performance degradations, while not increasing the plant IT budget, overburdening the existing staff, and risking regulatory non-compliance. As they move to meet the reliability challenge, pharma executives must understand the language of providing 99.999 percent uptime. There are many IT product and service vendors that tout phrases like "high-availability," "high reliability," and "continuous availability" for their products and services, but few of them provide 99.999 percent uptime. This article defines continuous availability as a system (hardware or software component) or integrated group of systems that is designed, manufactured, and delivered with an availability of 99.999 percent uptime or more, and is maintained at this level through an ongoing quality management process.


While most industries consider 97 to 98 percent information system availability excellent performance, the remaining two or three percent can represent huge financial losses and risk of non-compliance for pharmaceutical EBR and PAT implementations.9 Failure rates as low as two to three percent are unacceptable because they break the process monitoring and record chain, which results in spoiled batches with all the accompanying losses. Without uninterrupted operation, EBR and PAT solutions will not pay off as a cost-effective, risk-based approach to electronic record compliance and the manufacturing efficiencies that go with it. Therefore, the IT infrastructure that supports these applications must exceed standard corporate benchmarks of reliability, availability, and uptime.

From the outside, a continuously available manufacturing infrastructure resembles a conventional IT environment. It consists of servers running applications, databases, storage, and networking components. The servers are linked with storage arrays by router-based networks running protocols over hard-wired and (more recently) wireless connections. In a manufacturing environment, interfaces with plant floor systems pull in data from individual process execution systems.

blog comments powered by Disqus



Lundbeck CEO Resigns Due to Code of Conduct Breach
November 24, 2014
GPhA Issues Statement on Generic Drug Costs
November 20, 2014
Amgen Opens Single-Use Manufacturing Plant in Singapore
November 20, 2014
Manufacturing Issues Crucial to Combating Ebola
November 20, 2014
FDA Requests Comments on Generic Drug Submission Criteria
November 20, 2014
Author Guidelines
Source: BioPharm International,
Click here